EcoTest is among the only small number of COVID-19 rapid antibody tests that have been authorized by FDA under Emergency Use Authorization (EUA) and that detect antibodies (IgM and IgG). EcoTest is actually a serology test. Serology tests use a patient's blood, serum, or plasma to find the presence of IgM and IgG antibodies. The EcoTest COVID-19 IgG/IgM rapid test is meant for use as an aid in identifying people who have an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. It is ideal for the qualitative detection and differentiation of antibodies to SARS-CoV-2 in humans, letting you know who ought to be directed for further medical diagnosis. Medical PPE Resource is a distributor of the EcoTest COVID-19 IgG/IgM rapid test in the United States. Contact us today and we would be happy to discuss your testing needs.
Medical PPE Resource is a leading distributor of the EcoTesT COVID-19 IgG/IgM rapid test in the United States.
Our EcoTesT COVID-19 rapid test device is designed for use as a guide in quick testing and identifying individuals for COVID-19 infection.
The EcoTest rapid testing kits have FDA emergency use authorization and detect IgM peaks beginning in the individual and IgG peaks later during the illness.
This combination delivers broader capture of patients exposed to the coronavirus.
The rapid test devices are quite helpful in today's global crisis.
The test device is easy to use without additional equipment is required.
The global Digital Rapid Influenza Diagnostic Test Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Digital Rapid Influenza Diagnostic Test Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/digital-rapid-influenza-diagnostic-test-market/download-sampleMarket DynamicsInfluenza viruses being responsible for the winter epidemics of respiratory illness among all age groups will be the primary trending factor for market growth.
These digital testing platforms eliminating the need for an operator to visualize and interpret test results will be a market booster.
These RIDTs with enhanced sensitivity of detection for the seasonal, novel, and variant influenza strains and meeting the FDA's criteria should expand appropriate patient management opportunities.
The possibility of false-positive results is the main hindrance to the growth of the market.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
